CCR2 and neoplasm: One study showed that circulating NK cells recruited to the tumor stroma express atypical chemokine receptor 2 (CCR2), which suppresses CCR2 expression in KLRG1-expressing NK cells and limits their movement within the lungs towards other metastatic deposits [57].